Fong Liu, MD

The Johns Hopkins Outpatient Pharmacy offers a full inventory of standard, specialty and over-the-counter medications, as well as the convenience of discharge medication processing. International patient pharmaceutical services are also available.

David Wolinsky was raised in the Chicago suburbs and stayed around the area to attend undergraduate and medical school at Northwestern University. Between these two programs, he spent two years in Bethesda at the NIH vaccine research center (VRC) studying immunology and working on projects related to HIV vaccine development as part of his post baccalaureate research fellowship. David followed his passion for psychiatry to the University of Michigan for a psychiatry residency, where he was exposed to a diverse patient population across a wide variety of clinical settings. With an interest in enhancing his own capacity for diagnosing and treating Substance Use Disorders, as well as developing research related to the pathogenesis of addiction and new treatment modalities, he pursued a fellowship in Addiction Psychiatry at the University of Michigan. David is excited to return to Maryland to work at Johns Hopkins Hospital on its Addiction Consultation service as well as the Intensive Treatment Unit and Motivated Behavior Units. Additionally, he is participating in research focusing on the evaluation and management of Cannabis Use Disorder and Cannabis Withdrawal Syndrome at the Behavioral Pharmacology Research Unit (BPRU).

Matthew Ippolito, M.D., Ph.D. is an Associate Professor of Medicine and the Director of Clinical Epidemiology for the Southern and Central Africa International Centers of Excellence for Malaria Research (ICEMR). He received his A.B. from Dartmouth College and his M.D. from the Geisel School of Medicine at Dartmouth. He completed his Internal Medicine Internship and Residency at the University of California, San Francisco, and fellowships in Infectious Diseases and Clinical Pharmacology at the Johns Hopkins University School of Medicine where he received his Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He also served in the Peace Corps in Ghana, West Africa. Dr. Ippolito specializes in global health and tropical infectious diseases with a research focus on malaria in sub-Saharan Africa. His NIH-supported research program explores the clinical pharmacology of antimalarial drugs and the genetic epidemiology of drug resistance. In his role as Director of Clinical Epidemiology for the Southern and Central Africa ICEMR, Dr. Ippolito designs and oversees clinical, translational, and epidemiological studies of malaria. Dr. Ippolito also serves as a Phase I and II clinical trialist for the LONGEVITY consortium, established to develop and deploy long-acting nanoformulations of essential anti-infective drugs. He is also a co-developer of a computer vision-based machine learning platform for malaria diagnostic and research applications, and serves on the editorial board of Frontiers in Malaria.